Skip to main content
H.R. 1720 117th Congress House

COVID–19 Medical Production Act

Official title: To provide additional funding under the Defense Production Act of 1950 related to medical supplies and equipment directly related to combating the COVID-19 pandemic, and for other purposes.

Introduced: March 9, 2021 Introduced by: Juan Vargas Democratic · California See on congress.gov
Health AppropriationsCardiovascular and respiratory healthEmergency medical services and trauma careHealth technology, devices, supplies
More subjectsShow fewer subjects
Immunology and vaccinationInfectious and parasitic diseasesManufacturingMedical tests and diagnostic methodsMilitary procurement, research, weapons developmentPublic contracts and procurementWorker safety and health
Sign in to write a letter

Free account. One morning email at most, only on days something moved. Already have one? Sign in.

This bill died when the 117th Congress ended
It never became law before the 117th Congress (2021–2022) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 2 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Mar 9, 2021
Referred to the House Committee on Financial Services.
Mar 9, 2021
Introduced in House
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Latest action March 9, 2021

Referred to the House Committee on Financial Services.

 Plain-English summary Congressional Research Service

COVID-19 Medical Production Act

This bill provides additional funding for FY2021 to acquire medical supplies, vaccines, and other equipment to combat COVID-19 (i.e., coronavirus disease 2019) using authorities under the Defense Production Act of 1950. That act confers on the President a broad set of authorities to influence domestic industry to provide essential materials and goods for the national defense.

This funding is available through FY2025. Beginning in FY2023, it may be used to meet public health needs to address any pathogen determined by the President to have the potential to create a public health emergency.

 Related & companion bills 1
  • HR 1319 American Rescue Plan Act of 2021
 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 1
 Cosponsors 1
All 1 Democratic 1
D
Waters, Maxine
California · Mar 9, 2021
Cite this page click to expand
APA
U.S. Congress. (2026). H.R. 1720: COVID–19 Medical Production Act. 117th Congress. Open America. https://openamerica.io/bill/117-HR-1720/
MLA
"H.R. 1720: COVID–19 Medical Production Act." 117th Congress, 2026, Open America, https://openamerica.io/bill/117-HR-1720/.
Bluebook (legal)
H.R. 1720, 117th Cong. (2026), https://openamerica.io/bill/117-HR-1720/.
Markdown link
[H.R. 1720: COVID–19 Medical Production Act](https://openamerica.io/bill/117-HR-1720/)
Report a problem